Literature DB >> 32476435

Sinonasal Squamous Cell Carcinoma Presentation and Outcome: A National Perspective.

Zaid Al-Qurayshi1, Ryan Smith1, Jarrett E Walsh1.   

Abstract

BACKGROUND: examine presentation and outcomes of sinonasal squamous cell carcinoma (SCC).
METHODS: A retrospective study utilizing the National Cancer Database, 2004 to 2015. The study population included adult patients diagnosed with primary sinonasal SCC.
RESULTS: A total of 537 patients were included. The mean age of the study population was 62.6 ± 12.7 years. The median follow-up time was 35.6 months (interquartile range: 8.6-55.9). The histological variants identified are: (i) 66.7% keratinizing SCC, (ii) 21.6% non-keratinizing SCC, (iii) 8.0% papillary SCC, and (iv) 3.7% spindle cell carcinoma. Stage at presentation was: (i) 33.3% T1-2, N0, (ii) 31.8% T3-4a, N0, (iii) 13.8% T1-4a, N+, (iv) 17.0% T4b,N0-3, (v) 4.1% M1. Human papilloma virus (HPV) status was available for 96 patients and tested positive in 24 (25.0%) patients. By histological variants, 5-year survival was lowest for spindle cell carcinoma (40.0%), and highest for papillary SCC (70.1%). HPV negative tumors had a 5-year survival of 26.4%, while HPV positive tumors had a 5-year survival of 57.1% (P = <.001). Of the 255 patients with T1-4a, N0-3, M0 who had surgery of the primary site, 31 (12.2%) patients underwent endoscopic approach. The risk of positive postsurgical margins was not significantly different comparing endoscopic to open approach (23.8% vs 24.1%, P >.99).
CONCLUSIONS: Sinonasal SCC could present at advanced stages in two-thirds of the population and exhibit a variety of histological subtypes. Like other sites of head and neck, HPV positive tumors are associated with a favorable prognosis. Endoscopic approach is comparable to open approach in terms of post-surgical margins.

Entities:  

Keywords:  anterior skull base; endoscopic surgery; human papilloma virus; sinonasal malignancy; survival

Mesh:

Year:  2020        PMID: 32476435     DOI: 10.1177/0003489420929048

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  4 in total

1.  A Clinical-Radiomics Nomogram Based on the Apparent Diffusion Coefficient (ADC) for Individualized Prediction of the Risk of Early Relapse in Advanced Sinonasal Squamous Cell Carcinoma: A 2-Year Follow-Up Study.

Authors:  Naier Lin; Sihui Yu; Mengyan Lin; Yiqian Shi; Wei Chen; Zhipeng Xia; Yushu Cheng; Yan Sha
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

2.  MiR-654-3p Constrains Proliferation, Invasion, and Migration of Sinonasal Squamous Cell Carcinoma via CREB1/PSEN1 Regulatory Axis.

Authors:  Xiao Cui; Ying Yang; Aihui Yan
Journal:  Front Genet       Date:  2022-01-12       Impact factor: 4.599

3.  Outcomes of Management of Sinonasal Malignancies at a Dedicated Cancer Institution: A Retrospective Study.

Authors:  Rahim Dhanani; Muhammad Faisal; Hamza Shahid; Kashif Iqbal Malik; Arif Jamshed; Raza Hussain
Journal:  Ann Maxillofac Surg       Date:  2021-07-24

Review 4.  Human Papillomavirus and Survival of Sinonasal Squamous Cell Carcinoma Patients: A Systematic Review and Meta-Analysis.

Authors:  Anish Sharma; Alice L Tang; Vinita Takiar; Trisha M Wise-Draper; Scott M Langevin
Journal:  Cancers (Basel)       Date:  2021-07-22       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.